Shu-Qin Dai (Shuqin Dai)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Ejection Fraction

Prognostic Factors

Top Venues

Cancer research

Journal of oncology

BioMed research international

Journal of clinical laboratory analysis

This page only lists publications with an associated author ORCID identifier.

Publications

Xue-Ping Wang, Zhonglian He, Wen Liu, Runkun Han, Hui-Lan Li, Shu-Qin Dai, Lin Zhang, Minjie Mao
Development of a Clinically Oriented Model to Predict Antitumor Effects after PD-1/PD-L1 Inhibitor Therapy. Journal of oncology 2022 (2022)
Yunyun Xiao, Yue Li, Dongni Shi, Xiaoqing Wang, Shu-Qin Dai, Muwen Yang, Lingzhi Kong, Boyu Chen, Xinjian Huang, Chuyong Lin, Wen-Ting Liao, Benke Xu, Xin Chen, Lishuai Wang, Xiangfu Chen, Ying Ouyang, Guozhen Liu, Heping Li, Libing Song
MEX3C-Mediated Decay of SOCS3 mRNA Promotes JAK2/STAT3 Signaling to Facilitate Metastasis in Hepatocellular Carcinoma. Cancer research 82 (22) (2022)
Xiao-Min Liu, Xiao-Hua Liu, Min-Jie Mao, Yi-Jun Liu, Jun-Ye Wang, Shu-Qin Dai
The automated processing algorithm to correct the test result of serum neuron-specific enolase affected by specimen hemolysis. Journal of clinical laboratory analysis 35 (9) (2021)
Min-Jie Mao, Xiao-Li Wei, Hui Sheng, Xue-Ping Wang, Xiao-Hui Li, Yi-Jun Liu, Shan Xing, Qi Huang, Shu-Qin Dai, Wan-Li Liu
Clinical Significance of Preoperative Albumin and Globulin Ratio in Patients with Gastric Cancer Undergoing Treatment. BioMed research international 2017 (2017)